Cell therapy using induced pluripotent stem (iPS) cells meets next-next generation DNA sequencing technology

Current Genomics

Volumn 10, Issue 5, 2009, Pages 303-305

  Nakayama, Manabu ^a,b,c  

^a KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Gene replacement therapy; Gene therapy; Human genome project; iPS; Next generation DNA sequencing; Personal genomics

Indexed keywords

ADENOVIRUS VECTOR; GENOMIC DNA; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR SOX4;

BIOTECHNOLOGY; CELL CULTURE; CELL THERAPY; DNA SEQUENCE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE TARGETING; GENE TECHNOLOGY; GENOMIC INSTABILITY; HUMAN; KERATINOCYTE; PLURIPOTENT STEM CELL; REPRODUCIBILITY; REVIEW; SOMATIC CELL;

IPS;

EID: 68949212369     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920209788921001     Document Type: Review

References (20)

1. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126, 663-676.
2. Vogel, G. Breakthrough of the year. Reprogramming Cells. Science, 2008, 322, 1766-1767.
3. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131, 861-872.
4. Yu, J.; Vodyanik, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; Jonsdottir, G.A.; Ruotti, V.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318, 1917-1920.
5. Stadtfeld, M.; Nagaya, M.; Utikal, J.; Weir, G.; Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322, 945-949.
6. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008, 322, 949-953.
7. Huangfu, D.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Snitow, M.; Chen, A.E.; Melton, D.A. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol., 2008, 26, 795-797.
8. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D.A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 2008, 26, 1269-1275.
9. Silva, J.; Barrandon, O.; Nichols, J.; Kawaguchi, J.; Theunissen, T.W.; Smith, A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol., 2008, 6, e253.
10. Shi, Y.; Do, J.T.; Desponts, C.; Hahm, H.S.; Scholer, H.R.; Ding, S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell, 2008, 2, 525-528.
11. Markoulaki, S.; Hanna, J.; Beard, C.; Carey, B.W.; Cheng, A.W.; Lengner, C.J.; Dausman, J.A.; Fu, D.; Gao, Q.; Wu, S.; Cassady, J.P.; Jaenisch, R. Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat. Biotechnol., 2009, 27, 169-171.
12. Sridharan, R.; Tchieu, J.; Mason, M.J.; Yachechko, R.; Kuoy, E.; Horvath, S.; Zhou, Q.; Plath, K. Role of the murine reprogramming factors in the induction of pluripotency. Cell, 2009, 136, 364-377.
13. Spits, C.; Mateizel, I.; Geens, M.; Mertzanidou, A.; Staessen, C.; Vandeskelde, Y.; Van der Elst, J.; Liebaers, I.; Sermon, K. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat. Biotechnol., 2008, 26, 1361-1363.
14. Lefort, N.; Feyeux, M.; Bas, C.; Feraud, O.; Bennaceur-Griscelli, A.; Tachdjian, G.; Peschanski, M.; Perrier, AL. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat. Biotechnol., 2008, 26, 1364-1366.
15. Mardis, E.R. Anticipating the 1,000 dollar genome. Genome Biol., 2006, 7, 112.
16. Wolinsky, H. The thousand-dollar genome. Genetic brinkmanship or personalized medicine? EMBO Rep., 2007, 8, 900-903.
17. Eid, J.; Fehr, A.; Gray, J.; Luong, K.; Lyle, J.; Otto, G.; Peluso, P.; Rank, D.; Baybayan, P.; Bettman, B.; Bibillo, A.; Bjornson, K.; Chaudhuri, B.; Christians, F.; Cicero, R.; Clark, S.; Dalal, R.; Dewinter, A.; Dixon, J.; Foquet, M.; Gaertner, A.; Hardenbol, P.; Heiner, C.; Hester, K.; Holden, D.; Kearns, G.; Kong, X.; Kuse, R.; Lacroix, Y.; Lin, S.; Lundquist, P.; Ma, C.; Marks, P.; Maxham, M.; Murphy, D.; Park, I.; Pham, T.; Phillips, M.; Roy, J.; Sebra, R.; Shen, G.; Sorenson, J.; Tomaney, A.; Travers, K.; Trulson, M.; Vieceli, J.; Wegener, J.; Wu, D.; Yang, A.; Zaccarin, D.; Zhao, P.; Zhong, F.; Korlach, J.; Turner, S. Real-time DNA sequencing from single polymerase molecules. Science, 2009, 323, 133-138.
18. Blow, N. DNA sequencing: generation next-next. Nature Methods 2008, 5, 267-274
19. Aasen, T.; Raya, A.; Barrero, MJ.; Garreta, E.; Consiglio, A.; Gonzalez, F.; Vassena, R.; Bǐlic, J.; Pekarik, V.; Tiscornia, G.; Edel, M.; Boue, S.; Belmonte, J.C. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol., 2008, 26, 1276-1284.
20. Hanna, J.; Wernig, M.; Markoulaki, S.; Sun, C.W.; Meissner, A.; Cassady, J.P.; Beard, C.; Brambrink, T.; Wu, L.C.; Townes, T.M.; Jaenisch, R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 2007, 318, 1920-1923.